SCHEMBL1633418

SCHEMBL1633418

CN1CCC(CNC(=O)c2cncc(-c3cccc4cnc(Nc5ccc(S(N)(=O)=O)cc5)nc34)c2)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAP4K4 O95819 2/20 0.46
▸ EGFR P00533 2/20 0.44
▸ JAK2 O60674 3/20 0.44
▸ BRD4 O60885 2/20 0.44
▸ MAPK10 P53779 1/20 0.42
▸ CDK1 P06493 1/20 0.42
▸ CDK2 P24941 1/20 0.42
▸ CDK9 P50750 1/20 0.42
▸ MTOR P42345 1/20 0.41
▸ SMG1 Q96Q15 1/20 0.41
▸ NAMPT P43490 1/20 0.41
▸ MAP4K1 Q92918 1/20 0.40
▸ IKBKB O14920 2/20 0.40
▸ IGF1R P08069 1/20 0.40
▸ JAK1 P23458 2/20 0.40
▸ TYK2 P29597 1/20 0.40
▸ JAK3 P52333 1/20 0.40
▸ CA2 P00918 1/20 0.40
▸ STK4 Q13043 1/20 0.40
▸ FGFR2 P21802 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1632764 0.89 BRD4 (0.51) EGFRJAK2BRD4MAPK10CDK1
SCHEMBL1633266 0.84 BRAF (0.52) MAP4K4MTORSMG1IKBKBCA2
SCHEMBL1632623 0.84 MAPK10 (0.53) EGFRJAK2BRD4MAPK10CDK2
SCHEMBL1632787 0.82 JAK2 (0.45) EGFRJAK2BRD4MAPK10CDK1
SCHEMBL1633437 0.80 JAK2 (0.54) EGFRJAK2MAPK10CDK1CDK2
SCHEMBL13498295 0.79 MTOR (0.62) EGFRJAK2BRD4MAPK10CDK1
SCHEMBL13498361 0.79 JAK2 (0.49) JAK2BRD4CDK1CDK2CDK9
SCHEMBL1633214 0.79 MAPK10 (0.50) EGFRJAK2BRD4MAPK10CDK1
SCHEMBL1633187 0.78 MTOR (0.60) EGFRJAK2BRD4MAPK10CDK2
SCHEMBL1633524 0.78 JAK2 (0.50) EGFRJAK2BRD4IKBKBTYK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 — — US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 — — US disclosed
Send feedback